Effectiveness of purified methylene blue in an experimental model of Mycobacterium ulcerans infection

Autor: Shady Asmar, Roger B. D. Tian, Michel Drancourt, Claude Napez, Hubert Lepidi

Publikováno v: International Journal of Antimicrobial Agents
International Journal of Antimicrobial Agents, Elsevier, 2017, 49 (3), pp.290-295. ⟨10.1016/j.ijantimicag.2016.11.012⟩
International Journal of Antimicrobial Agents, 2017, 49 (3), pp.290-295. ⟨10.1016/j.ijantimicag.2016.11.012⟩

International audience; Mycobacterium ulcerans is responsible for Buruli ulcer, characterised by extensive, disabling ulcers. Standard treatment combining rifampicin and streptomycin exposes patients to toxicity and daily painful injections. In this

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ea98a6610a4d4accf38a300a89aa9c37
https://pubmed.ncbi.nlm.nih.gov/28131607